 | • レポートコード：D0804-09737 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、Pd-1およびPd-L1阻害剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。Pd-1およびPd-L1阻害剤の種類別市場規模（PD-1、PD-L1）、用途別市場規模（病院薬局、小売薬局、専門薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bristol-Myers Squibb、Novartis、Sanofi、Merck、AstraZeneca、F. Hoffmann-La Roche、Celgene、Gilead Sciences、Amgen、Pfizer ・地域別グローバル市場分析 2015年-2020年 ・Pd-1およびPd-L1阻害剤の北米市場（アメリカ、カナダ、メキシコ） ・Pd-1およびPd-L1阻害剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・Pd-1およびPd-L1阻害剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・Pd-1およびPd-L1阻害剤の南米市場（ブラジル、アルゼンチン） ・Pd-1およびPd-L1阻害剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：PD-1、PD-L1 ・用途別分析：病院薬局、小売薬局、専門薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Pd-1 and Pd-L1 Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pd-1 and Pd-L1 Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pd-1 and Pd-L1 Inhibitors market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pd-1 and Pd-L1 Inhibitors market has been segmented into
PD-1
PD-L1
By Application, Pd-1 and Pd-L1 Inhibitors has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Specialty Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pd-1 and Pd-L1 Inhibitors market presented in the report. This section sheds light on the sales growth of different regional and country-level Pd-1 and Pd-L1 Inhibitors markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pd-1 and Pd-L1 Inhibitors market.
The report offers in-depth assessment of the growth and other aspects of the Pd-1 and Pd-L1 Inhibitors market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Pd-1 and Pd-L1 Inhibitors Market Share Analysis
Pd-1 and Pd-L1 Inhibitors competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pd-1 and Pd-L1 Inhibitors sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pd-1 and Pd-L1 Inhibitors sales, revenue and market share for each player covered in this report.
The major players covered in Pd-1 and Pd-L1 Inhibitors are:
Bristol-Myers Squibb
Novartis
Sanofi
Merck
AstraZeneca
F. Hoffmann-La Roche
Celgene
Gilead Sciences
Amgen
Pfizer
Among other players domestic and global, Pd-1 and Pd-L1 Inhibitors market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pd-1 and Pd-L1 Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pd-1 and Pd-L1 Inhibitors, with price, sales, revenue and global market share of Pd-1 and Pd-L1 Inhibitors in 2018 and 2019.
Chapter 3, the Pd-1 and Pd-L1 Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pd-1 and Pd-L1 Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pd-1 and Pd-L1 Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pd-1 and Pd-L1 Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Pd-1 and Pd-L1 Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pd-1 and Pd-L1 Inhibitors Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 PD-1
1.2.3 PD-L1
1.3 Market Analysis by Application
1.3.1 Overview: Global Pd-1 and Pd-L1 Inhibitors Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Specialty Pharmacies
1.4 Overview of Global Pd-1 and Pd-L1 Inhibitors Market
1.4.1 Global Pd-1 and Pd-L1 Inhibitors Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bristol-Myers Squibb SWOT Analysis
2.1.4 Bristol-Myers Squibb Product and Services
2.1.5 Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AstraZeneca SWOT Analysis
2.5.4 AstraZeneca Product and Services
2.5.5 AstraZeneca Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 F. Hoffmann-La Roche
2.6.1 F. Hoffmann-La Roche Details
2.6.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 F. Hoffmann-La Roche SWOT Analysis
2.6.4 F. Hoffmann-La Roche Product and Services
2.6.5 F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Celgene
2.7.1 Celgene Details
2.7.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Celgene SWOT Analysis
2.7.4 Celgene Product and Services
2.7.5 Celgene Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Gilead Sciences
2.8.1 Gilead Sciences Details
2.8.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Gilead Sciences SWOT Analysis
2.8.4 Gilead Sciences Product and Services
2.8.5 Gilead Sciences Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Amgen SWOT Analysis
2.9.4 Amgen Product and Services
2.9.5 Amgen Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pfizer SWOT Analysis
2.10.4 Pfizer Product and Services
2.10.5 Pfizer Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pd-1 and Pd-L1 Inhibitors Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pd-1 and Pd-L1 Inhibitors Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pd-1 and Pd-L1 Inhibitors Manufacturer Market Share in 2019
3.3.2 Top 6 Pd-1 and Pd-L1 Inhibitors Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Market Share by Regions
4.1.1 Global Pd-1 and Pd-L1 Inhibitors Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pd-1 and Pd-L1 Inhibitors Revenue and Market Share by Regions (2015-2020)
4.2 North America Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
4.3 Europe Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
4.5 South America Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Market Share by Country
5.1.1 North America Pd-1 and Pd-L1 Inhibitors Sales and Market Share by Country (2015-2020)
5.1.2 North America Pd-1 and Pd-L1 Inhibitors Revenue and Market Share by Country (2015-2020)
5.2 United States Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
5.3 Canada Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
5.4 Mexico Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Market Share by Country
6.1.1 Europe Pd-1 and Pd-L1 Inhibitors Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pd-1 and Pd-L1 Inhibitors Revenue and Market Share by Country (2015-2020)
6.2 Germany Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
6.3 UK Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
6.4 France Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
6.5 Russia Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
6.6 Italy Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pd-1 and Pd-L1 Inhibitors Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pd-1 and Pd-L1 Inhibitors Revenue and Market Share by Regions (2015-2020)
7.2 China Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
7.3 Japan Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
7.4 Korea Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
7.5 India Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
7.7 Australia Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Market Share by Country
8.1.1 South America Pd-1 and Pd-L1 Inhibitors Sales and Market Share by Country (2015-2020)
8.1.2 South America Pd-1 and Pd-L1 Inhibitors Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
8.3 Argentina Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
9.3 Turkey Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
9.4 Egypt Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
9.5 South Africa Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pd-1 and Pd-L1 Inhibitors Sales and Market Share by Type (2015-2020)
10.2 Global Pd-1 and Pd-L1 Inhibitors Revenue and Market Share by Type (2015-2020)
10.3 Global Pd-1 and Pd-L1 Inhibitors Price by Type (2015-2020)
11 Global Pd-1 and Pd-L1 Inhibitors Market Segment by Application
11.1 Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2015-2020)
11.2 Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Application (2015-2020)
11.3 Global Pd-1 and Pd-L1 Inhibitors Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pd-1 and Pd-L1 Inhibitors Sales, Revenue and Growth Rate (2021-2025)
12.2 Pd-1 and Pd-L1 Inhibitors Market Forecast by Regions (2021-2025)
12.2.1 North America Pd-1 and Pd-L1 Inhibitors Market Forecast (2021-2025)
12.2.2 Europe Pd-1 and Pd-L1 Inhibitors Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pd-1 and Pd-L1 Inhibitors Market Forecast (2021-2025)
12.2.4 South America Pd-1 and Pd-L1 Inhibitors Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Market Forecast (2021-2025)
12.3 Pd-1 and Pd-L1 Inhibitors Market Forecast by Type (2021-2025)
12.3.1 Global Pd-1 and Pd-L1 Inhibitors Sales Forecast by Type (2021-2025)
12.3.2 Global Pd-1 and Pd-L1 Inhibitors Market Share Forecast by Type (2021-2025)
12.4 Pd-1 and Pd-L1 Inhibitors Market Forecast by Application (2021-2025)
12.4.1 Global Pd-1 and Pd-L1 Inhibitors Sales Forecast by Application (2021-2025)
12.4.2 Global Pd-1 and Pd-L1 Inhibitors Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Pd-1 and Pd-L1 Inhibitors Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pd-1 and Pd-L1 Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pd-1 and Pd-L1 Inhibitors Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Major Business
Table 9. Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Total Revenue (USD Million) (2018-2019)
Table 10. Bristol-Myers Squibb SWOT Analysis
Table 11. Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Product and Services
Table 12. Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Pd-1 and Pd-L1 Inhibitors Major Business
Table 15. Novartis Pd-1 and Pd-L1 Inhibitors Total Revenue (USD Million) (2018-2019)
Table 16. Novartis SWOT Analysis
Table 17. Novartis Pd-1 and Pd-L1 Inhibitors Product and Services
Table 18. Novartis Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Pd-1 and Pd-L1 Inhibitors Major Business
Table 21. Sanofi Pd-1 and Pd-L1 Inhibitors Total Revenue (USD Million) (2018-2019)
Table 22. Sanofi SWOT Analysis
Table 23. Sanofi Pd-1 and Pd-L1 Inhibitors Product and Services
Table 24. Sanofi Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck Basic Information, Manufacturing Base and Competitors
Table 26. Merck Pd-1 and Pd-L1 Inhibitors Major Business
Table 27. Merck Pd-1 and Pd-L1 Inhibitors Total Revenue (USD Million) (2018-2019)
Table 28. Merck SWOT Analysis
Table 29. Merck Pd-1 and Pd-L1 Inhibitors Product and Services
Table 30. Merck Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Pd-1 and Pd-L1 Inhibitors Major Business
Table 33. AstraZeneca Pd-1 and Pd-L1 Inhibitors Total Revenue (USD Million) (2018-2019)
Table 34. AstraZeneca SWOT Analysis
Table 35. AstraZeneca Pd-1 and Pd-L1 Inhibitors Product and Services
Table 36. AstraZeneca Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 38. F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Major Business
Table 39. F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Total Revenue (USD Million) (2018-2019)
Table 40. F. Hoffmann-La Roche SWOT Analysis
Table 41. F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Product and Services
Table 42. F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Celgene Basic Information, Manufacturing Base and Competitors
Table 44. Celgene Pd-1 and Pd-L1 Inhibitors Major Business
Table 45. Celgene Pd-1 and Pd-L1 Inhibitors Total Revenue (USD Million) (2018-2019)
Table 46. Celgene SWOT Analysis
Table 47. Celgene Pd-1 and Pd-L1 Inhibitors Product and Services
Table 48. Celgene Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 50. Gilead Sciences Pd-1 and Pd-L1 Inhibitors Major Business
Table 51. Gilead Sciences Pd-1 and Pd-L1 Inhibitors Total Revenue (USD Million) (2018-2019)
Table 52. Gilead Sciences SWOT Analysis
Table 53. Gilead Sciences Pd-1 and Pd-L1 Inhibitors Product and Services
Table 54. Gilead Sciences Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Amgen Basic Information, Manufacturing Base and Competitors
Table 56. Amgen Pd-1 and Pd-L1 Inhibitors Major Business
Table 57. Amgen Pd-1 and Pd-L1 Inhibitors Total Revenue (USD Million) (2018-2019)
Table 58. Amgen SWOT Analysis
Table 59. Amgen Pd-1 and Pd-L1 Inhibitors Product and Services
Table 60. Amgen Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Pd-1 and Pd-L1 Inhibitors Major Business
Table 63. Pfizer Pd-1 and Pd-L1 Inhibitors Total Revenue (USD Million) (2018-2019)
Table 64. Pfizer SWOT Analysis
Table 65. Pfizer Pd-1 and Pd-L1 Inhibitors Product and Services
Table 66. Pfizer Pd-1 and Pd-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Pd-1 and Pd-L1 Inhibitors Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Pd-1 and Pd-L1 Inhibitors Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Pd-1 and Pd-L1 Inhibitors Sales by Regions (2015-2020) (K Units)
Table 70. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Regions (2015-2020)
Table 71. Global Pd-1 and Pd-L1 Inhibitors Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Pd-1 and Pd-L1 Inhibitors Sales by Countries (2015-2020) (K Units)
Table 73. North America Pd-1 and Pd-L1 Inhibitors Sales Market Share by Countries (2015-2020)
Table 74. North America Pd-1 and Pd-L1 Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Countries (2015-2020)
Table 76. Europe Pd-1 and Pd-L1 Inhibitors Sales by Countries (2015-2020) (K Units)
Table 77. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Countries (2015-2020)
Table 78. Europe Pd-1 and Pd-L1 Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Pd-1 and Pd-L1 Inhibitors Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Pd-1 and Pd-L1 Inhibitors Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Pd-1 and Pd-L1 Inhibitors Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Pd-1 and Pd-L1 Inhibitors Sales by Countries (2015-2020) (K Units)
Table 83. South America Pd-1 and Pd-L1 Inhibitors Sales Market Share by Countries (2015-2020)
Table 84. South America Pd-1 and Pd-L1 Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Countries (2015-2020)
Table 90. Global Pd-1 and Pd-L1 Inhibitors Sales by Type (2015-2020) (K Units)
Table 91. Global Pd-1 and Pd-L1 Inhibitors Sales Share by Type (2015-2020)
Table 92. Global Pd-1 and Pd-L1 Inhibitors Revenue by Type (2015-2020) (USD Million)
Table 93. Global Pd-1 and Pd-L1 Inhibitors Revenue Share by Type (2015-2020)
Table 94. Global Pd-1 and Pd-L1 Inhibitors Sales by Application (2015-2020) (K Units)
Table 95. Global Pd-1 and Pd-L1 Inhibitors Sales Share by Application (2015-2020)
Table 96. Global Pd-1 and Pd-L1 Inhibitors Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Pd-1 and Pd-L1 Inhibitors Market Share Forecast by Regions (2021-2025)
Table 98. Global Pd-1 and Pd-L1 Inhibitors Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Pd-1 and Pd-L1 Inhibitors Market Share Forecast by Type (2021-2025)
Table 100. Global Pd-1 and Pd-L1 Inhibitors Sales Forecast by Application (2021-2025)
Table 101. Global Pd-1 and Pd-L1 Inhibitors Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Pd-1 and Pd-L1 Inhibitors Picture
Figure 2. Global Sales Market Share of Pd-1 and Pd-L1 Inhibitors by Type in 2019
Figure 3. PD-1 Picture
Figure 4. PD-L1 Picture
Figure 5. Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application in 2018
Figure 6. Hospital Pharmacies Picture
Figure 7. Retail Pharmacies Picture
Figure 8. Specialty Pharmacies Picture
Figure 9. Global Pd-1 and Pd-L1 Inhibitors Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Pd-1 and Pd-L1 Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Manufacturer in 2019
Figure 30. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Pd-1 and Pd-L1 Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Pd-1 and Pd-L1 Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Pd-1 and Pd-L1 Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Regions (2015-2020)
Figure 37. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Regions in 2018
Figure 38. North America Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure 39. Europe Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure 41. South America Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020)
Figure 43. North America Pd-1 and Pd-L1 Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Pd-1 and Pd-L1 Inhibitors Sales Market Share by Countries (2015-2020)
Figure 45. North America Pd-1 and Pd-L1 Inhibitors Sales Market Share by Countries in 2018
Figure 46. North America Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Countries in 2018
Figure 48. United States Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Pd-1 and Pd-L1 Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Countries in 2019
Figure 54. Germany Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Pd-1 and Pd-L1 Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Pd-1 and Pd-L1 Inhibitors Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Regions 2019
Figure 62. China Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Pd-1 and Pd-L1 Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Pd-1 and Pd-L1 Inhibitors Sales Market Share by Countries in 2019
Figure 69. South America Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Countries in 2019
Figure 70. Brazil Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Pd-1 and Pd-L1 Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Pd-1 and Pd-L1 Inhibitors Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Pd-1 and Pd-L1 Inhibitors Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Pd-1 and Pd-L1 Inhibitors Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Pd-1 and Pd-L1 Inhibitors Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Pd-1 and Pd-L1 Inhibitors Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Pd-1 and Pd-L1 Inhibitors Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Pd-1 and Pd-L1 Inhibitors Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
レニン阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Renin-Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…- ブルトン型チロシンキナーゼ（BTK）阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Bruton Tyrosine Kinase (BTK) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…
- アンジオテンシン変換酵素（ACE）阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Angiotensin Converting Enzyme (ACE) Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Th…
- 揮発性腐食防止剤（VCI）の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Volatile Corrosion Inhibitors (VCI) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 揮発性腐食防止剤（VCI）梱包材の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Volatile Corrosion Inhibitors (VCI) Packaging Material market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market p…